Research Topics
Species | Daphne de JongSummaryAffiliation: The Netherlands Cancer Institute Country: The Netherlands Publications
| Collaborators
|
Detail Information
Publications
Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker ConsortiumDaphne de Jong
Netherlands Cancer Institute, Amsterdam, The Netherlands
J Clin Oncol 25:805-12. 2007....
Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factorsDaphne de Jong
Department of Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
J Clin Oncol 23:6358-63. 2005..These insights may lead to improvement of risk stratification, but most importantly will provide tools for developing new targets and strategies for treatment...
Inflammatory cells and immune microenvironment in malignant lymphomaD De Jong
Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
J Intern Med 264:528-36. 2008..In this review, the functional interactions and clinical consequences of these insights are discussed in indolent and aggressive B-cell lymphomas and in classical Hodgkin's lymphoma...
Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocolsDaphne de Jong
Dept of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Haematologica 94:70-7. 2009..The precise nature of the cell populations is still unclear and published data on their prognostic significance are highly conflicting. This may be partly due to heterogeneous composition and treatments...
Lymphocyte-rich classical Hodgkin lymphoma (LRCHL): clinico-pathological characteristics and outcome of a rare entityD De Jong
The Netherlands Cancer Institute, Amsterdam, The Netherlands
Ann Oncol 17:141-5. 2006..To investigate the proportion, clinical characteristics and outcome of lymphocyte-rich classical Hodgkin lymphoma (LRCHL) in relation to nodular lymphocyte predominant HL (NLPHL) and classical HL (cHL)...
Anaplastic large-cell lymphoma in women with breast implantsDaphne de Jong
Department of Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066CX, The Netherlands
JAMA 300:2030-5. 2008..Similar cases have been reported in the literature. Although an increased risk of ALCL in patients with breast prostheses has been speculated, no studies have been conducted so far...
Predicting transformation in follicular lymphomaDaphne de Jong
Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Leuk Lymphoma 50:1406-11. 2009....
The molecular background of aggressive B cell lymphomas as a basis for targeted therapyDaphne de Jong
Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
J Pathol 223:274-82. 2011..In this review, the molecular background and the consequences of the molecular alterations in the context of the consequences for treatment in aggressive B cell lymphoma are discussed...
Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)D De Jong
Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
J Clin Pathol 62:128-38. 2009..In this study, an international collaboration of clinical lymphoma research groups has concentrated on validation and standardisation of immunohistochemistry of the currently potentially interesting prognostic markers in DLBCL...
The microenvironment in follicular lymphomaDaphne de Jong
The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
Best Pract Res Clin Haematol 24:135-46. 2011..These insights may thoroughly change the therapeutic approaches in FL and translate into programs that combine direct cytotoxic and indirect immunomodulatory aspects...
Anaplastic plasmacytoma of mouse--establishing parallels between subtypes of mouse and human plasma cell neoplasiaDaphne de Jong
Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
J Pathol 221:242-7. 2010....
Oncogenesis and classification of mixed-type liposarcoma: a radiological, histopathological and molecular biological analysisRonald S A de Vreeze
Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Int J Cancer 128:778-86. 2011..For treatment stratification, detailed classification including molecular support should be performed in tumors with heterogeneous MRI features...
Multifocal myxoid liposarcoma--metastasis or second primary tumor?: a molecular biological analysisRonald de Vreeze
Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
J Mol Diagn 12:238-43. 2010..This study supports the metastatic nature of apparent multifocal myxoid/round cell liposarcoma...
Added Value of Molecular Biological Analysis in Diagnosis and Clinical Management of Liposarcoma: A 30-Year Single-Institution ExperienceRonald S A de Vreeze
Departments of Surgical Oncology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Ann Surg Oncol 17:686-93. 2010..Treatment decisions and prognosis assessment for liposarcoma is based on a classification that depends on morphological and genetic features. Revisions by experienced referral pathologists are often advocated...
Long-term results of stomach-conserving therapy in gastric MALT lymphomaConny Vrieling
Department of Radiation Oncology, Netherlands Cancer Institute Antoni van Leeuwenhoek ziekenhuis, Amsterdam, The Netherlands
Radiother Oncol 87:405-11. 2008..To evaluate long-term results of stomach-conserving therapy and to assess the value of histological probable minimal residual disease (pMRD) in predicting outcome in patients with gastric MALT lymphoma...
In vivo p53 response and immune reaction underlie highly effective low-dose radiotherapy in follicular lymphomaLaurent Knoops
Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Blood 110:1116-22. 2007..Moreover, this study is the first in vivo report of the radiation-induced p53 apoptotic response in patients and suggests that this apoptotic response is not immunologically silent...
Treatment of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with fludarabine: effect on tumor microenvironmentJan Paul de Boer
Department of Medical Oncology, Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Leuk Lymphoma 52:2262-9. 2011..In addition an increase in density of FOXP3 + cells (i.e. Tregs) was seen (p = 0.047). These alterations in different T-cell subsets were not observed in gastric biopsy samples of patients treated with HP-eradication only...
Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphomaAnnuska M Glas
Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
J Clin Oncol 25:390-8. 2007..Despite the generally favorable clinical course in follicular lymphoma (FL), a minority of patients have a poor prognosis-with death within 3 years of diagnosis-most often due to transformation to aggressive disease...
Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphomaBerthe M P Aleman
Department of Radiotherapy, The Netherlands Cancer Institute, Amsterdam
Int J Radiat Oncol Biol Phys 67:19-30. 2007..The purpose of this study was to describe the role of radiotherapy in patients with advanced HL who were in partial remission (PR) after chemotherapy...
Low-dose involved-field radiotherapy as alternative treatment of nodular lymphocyte predominance Hodgkin's lymphomaRick L M Haas
Department of Radiotherapy, The Netherlands Cancer Institute Amsterdam, Amsterdam, The Netherlands
Int J Radiat Oncol Biol Phys 74:1199-202. 2009..Considerable discussion is ongoing on the treatment of primary and relapsed disease...
Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatmentAnnuska M Glas
Netherlands Cancer Institute, Division of Diagnostic Oncology, Central Microarray Facility, Amsterdam, The Netherlands
Blood 105:301-7. 2005....
Delineation of chondroid lipoma: an immunohistochemical and molecular biological analysisRonald S A de Vreeze
Department of Surgical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX, Amsterdam, The Netherlands
Sarcoma 2011:638403. 2011..Conclusions. Chondroid lipoma is extremely rare and has several and more prevalent histological mimics. The differential diagnosis of chondroid lipomas can be unraveled using immunohistochemical and molecular support...
Effectiveness of radiotherapy in myxoid sarcomas is associated with a dense vascular patternRonald S A de Vreeze
Department of Surgical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Int J Radiat Oncol Biol Phys 72:1480-7. 2008..Here we describe our results with preoperative RT and propose a mechanism explaining the high sensitivity based on the distinctive vascularization pattern of MLS...
In vivo imaging of radiation-induced apoptosis in follicular lymphoma patientsRick L M Haas
Department of Radiotherapy, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Int J Radiat Oncol Biol Phys 59:782-7. 2004..To evaluate (99m)Tc-Annexin-V (TAV) scintigraphy in monitoring radiation-induced apoptotic cell death in follicular lymphoma (FL) patients...
Lack of Bcl-2 expression in follicular lymphoma may be caused by mutations in the BCL2 gene or by absence of the t(14;18) translocationMargit Schraders
Department of Pathology, University Medical Centre Nijmegen, Nijmegen, The Netherlands
J Pathol 205:329-35. 2005..These findings may have consequences for the use of Bcl-2 immunohistochemistry for diagnostic purposes...
Familial gastric cancer: guidelines for diagnosis, treatment and periodic surveillanceIrma Kluijt
Family Cancer Clinic, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Fam Cancer 11:363-9. 2012..National and international collaboration is warranted to improve the quality of research by increasing the size of study cohorts...
An α-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancerIan J Majewski
Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands
J Pathol 229:621-9. 2013..We also detected somatic mutations in one tumour and found substantial overlap with genes mutated in sporadic gastric cancer, including PIK3CA, ARID1A, MED12 and MED23...
Hereditary causes of kidney tumoursPriscilla Helene Axwijk
The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Eur J Clin Invest 40:433-9. 2010..Hereditary renal cancer accounts for about 2-4% of cases. Recognition of this subgroup by clinicians is important because of the possibility of severe medical consequences for patients and their relatives...
Dissemination patterns in non-gastric MALT lymphomaJan Paul de Boer
Dept of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
Haematologica 93:201-6. 2008....
Poor outcomes of chronic active Epstein-Barr virus infection and hemophagocytic lymphohistiocytosis in non-Japanese adult patientsGabe S Sonke
Departments of 1Medical Oncology and 2Pathology, Antoni van Leeuwenhoek Hospital Netherlands Cancer Institute, 1006 BE Amsterdam, The Netherlands
Clin Infect Dis 47:105-8. 2008....
CDH1-related hereditary diffuse gastric cancer syndrome: clinical variations and implications for counselingIrma Kluijt
Family Cancer Clinic, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Int J Cancer 131:367-76. 2012..The relationship between CL/P and CDH1 needs further study to inform future parents from hereditary diffuse gastric cancer (HDGC) families adequately...
Primary retroperitoneal myxoid/round cell liposarcoma is a nonexisting disease: an immunohistochemical and molecular biological analysisRonald S A de Vreeze
Department of Surgical Oncology, Antoni van Leeuwenhoek Hospital, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Mod Pathol 22:223-31. 2009..Moreover, finding of myxoid/round cell liposarcoma translocations in a retroperitoneal localization is highly suggestive of metastasis and should prompt search for a primary localization outside the retroperitoneum...
Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primaryHugo M Horlings
Division of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
J Clin Oncol 26:4435-41. 2008..Currently, the success rate of the diagnostic work-up is only 20% to 30%. Our goal was to evaluate the contribution of gene expression profiling for routine clinical practice in patients with ACUP...
Alkylphospholipids inhibit capillary-like endothelial tube formation in vitro: antiangiogenic properties of a new class of antitumor agentsShuraila F Zerp
Division of Cellular Biochemistry, Department of Pathology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Plesmanlaan, CX Amsterdam, The Netherlands
Anticancer Drugs 19:65-75. 2008..Interference with the angiogenic process represents a novel mode of action of APLs and might significantly contribute to the antitumor effect of these compounds...
Serum soluble CD27, but not thymidine kinase, is an independent prognostic factor for outcome in indolent non-Hodgkin's lymphomaMarleen Kok
Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Tumour Biol 24:53-60. 2003..A study in a larger cohort of patients is required to validate this approach...
Pulmonary squamous cell carcinoma following head and neck squamous cell carcinoma: metastasis or second primary?Tom W Geurts
Department of ORL, Academic Medical Center, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Clin Cancer Res 11:6608-14. 2005..To distinguish a metastasis from a second primary tumor in patients with a history of head and neck squamous cell carcinoma and subsequent pulmonary squamous cell carcinoma...
Thallium-201-chloride scintigraphy in staging and monitoring radiotherapy response in follicular lymphoma patientsRick L M Haas
Department of Radiotherapy, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands
Radiother Oncol 69:323-8. 2003..If an FL patient with a positive 201Tl-S at diagnosis is treated by irradiation, the treatment response can be reliably ascertained by only performing a 201Tl-S...
Very late relapse in diffuse large B-cell lymphoma represents clonally related disease and is marked by germinal center cell featuresDaphne de Jong
Department of Pathology, Biomedics and Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
Blood 102:324-7. 2003..5 years (P =.005). In conclusion, we have found evidence that late-relapsing DLBCL represents truly clonally related disease episodes in most cases and that this clinical behavior may be related to the biologic features of GC cells...
Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivityRichard J Bende
Department of Pathology, Academic Medical Center, Netherlands Cncer Institute, 1105 AZ Amsterdam, The Netherlands
J Exp Med 201:1229-41. 2005..Interestingly, RF-CDR3 homology and t(11;18) appeared to be mutually exclusive features and RF-CDR3 homology was not encountered in any of the 19 pulmonary MALT lymphomas studied...
Infiltration of activated dendritic cells and T cells in renal cell carcinoma following combined cytokine immunotherapyNatascha Verra
Department of Immunology, Netherlands Cancer Institute, Amsterdam
Eur Urol 48:527-33. 2005..CONCLUSIONS: These findings show increased infiltration of activated, mature DC and functionally active CD8+ T cells in renal tumors, which may suggest clinical potential of cytokine immunotherapy...
T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradicationHongxiang Liu
Department of Histopathology, University College London, London, England
Gastroenterology 122:1286-94. 2002..pylori eradication. Detection of the translocation should help the clinical management of patients with gastric MALT lymphoma...
Comprehensive analysis of GST-pi expression in B-cell lymphomas: Correlation with histological subtypes and survivalCatherine Thieblemont
Leuk Lymphoma 49:1403-6. 2008
The microarray way to tailored cancer treatmentDaphne de Jong
Nat Med 8:13-4. 2002
Mechanisms and effects of loss of human leukocyte antigen class II expression in immune-privileged site-associated B-cell lymphomaMarije Booman
Department of Pathology and Laboratory Medicine, University Medical Center Groningen, Groningen, Netherlands
Clin Cancer Res 12:2698-705. 2006....
The role of the p53 pathway in the treatment of follicular lymphomaLaurent Knoops
Experimental Medicine Unit, de Duve Institute, Universite Catholique de Louvain, Brussels, Belgium
Cell Cycle 7:436-9. 2008..These insights have implications for the design of new protocols in the treatment of follicular lymphoma...
Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemiaShelly R Gunn
The University of Texas Health Science Center at San Antonio, Department of Pathology, Mail Code 7750, 7703 Floyd Curl Dr, San Antonio, TX, USA
J Mol Diagn 10:442-51. 2008..5%); 13 hybridizations (4.5%) were discordant because of clonal populations that comprised less than 30% of the sample. Array CGH is a powerful, cost-effective tool for genome-wide risk assessment in the clinical evaluation of CLL...
